Neuroimmunological diseases and their treatment compromise the immune system, thereby
increasing the risk of infections and serious illness. Consequently, vaccinations to protect …

Population-level data on COVID-19 vaccine uptake in pregnancy and SARS-CoV-2 infection
outcomes are lacking. We describe COVID-19 vaccine uptake and SARS-CoV-2 infection in …

Background The safety of coronavirus disease 2019 (COVID-19) vaccines during pregnancy
is a particular concern. Here, we addressed the neonatal outcomes after maternal …

Background: Optimization of COVID-19 vaccination rate among healthcare personnel is of
utmost priority to secure provision of uninterrupted care and to protect the most vulnerable …

Background A safe and effective vaccine is the ultimate key to mitigating the COVID-19
pandemic. Vaccine acceptance is influenced by various factors, including perceptions about …

The outbreak of COVID-19 started in December 2019 and spread rapidly all over the world.
It became clear that the development of an effective vaccine was the only way to stop the …

Abstract Coronavirus disease 2019 (COVID‐19), the highly contagious viral disease caused
by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has spread worldwide …

Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)‐induced COVID‐19 is a
complicated disease. Clinicians are continuously facing difficulties to treat infected patients …

Abstract The coronavirus disease 2019 (COVID-19) represents a global health and
economic challenge. Hepatic injuries have been approved to be associated with severe …

Background In reports of adverse reactions following vaccination with the coronavirus
disease 2019 (COVID-19) vaccines, there have been fewer reports of concern for menstrual …